PD
MRVI icon

Point72 (DIFC)’s Maravai LifeSciences MRVI Stock Holding History

Point72 (DIFC)’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.43M Sell
2,588,887
-1,130,615
-30% -$2.89M 0.52% 57
2025
Q2 		$8.96M Buy
3,719,502
+2,163,164
+139% +$4.55M 0.71% 68
2025
Q1 		$3.44M Buy
1,556,338
+561
+0% +$2.22K 0.33% 202
2024
Q4 		$8.48M Sell
1,555,777
-1,104,601
-42% -$7.11M 0.76% 71
2024
Q3 		$22.1M Buy
+2,660,378
New +$23M 1.71% 23

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.03B AUM 19.83% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return